News
- World Hepatitis Day: fast-tracking the elimination of hepatitis B among mothers and children
- New country support package launched to accelerate salt reduction in the WHO European Region
- FDA Requiring Labeling Changes for Opioid Pain Medicines, Opioid Use Disorder Medicines Regarding Naloxone
- Canada Invests in Smart Grid Technology for London Net-Zero Energy Community
- Countries commit to meeting SDGs in face of pandemic
- Over 10 000 health workers in Africa infected with COVID-19
- Government of Canada invests $5.7M in new research network to study deadly blood infections
- FDA Proposes New Rule on Reporting Requirements
- WHO Regional Director for Europe signs agreement for new centre of excellence and visits Gaziantep, marking 60 years of cooperation with Turkey
- V-MAX Herbal Tablets
- COVID-19: EMA sets up infrastructure for real-world monitoring of treatments and vaccines
- Salmonella Investigation Notice
- U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine
- HHS Announces National COVID-19 Testing Implementation Forum
- New COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
- FDA Extends Enforcement Discretion Policy for Certain Regenerative Medicine Products
- WHO helps reshape hospitals as COVID-19 eases its grip
- OCR Issues Guidance on Civil Rights Protections Prohibiting Race, Color, and National Origin Discrimination During COVID-19
- Women leaders call for integrating mental health into COVID-19 response
- One million patients reported as recovered from COVID-19 in WHO’s Eastern Mediterranean Region
- FDA Notifies Companies, Including Puff Bar, to Remove Flavored Disposable E-Cigarettes and Youth-Appealing E-Liquids from Market for Not Having Required Authorization
- WHO urges greater COVID-19 health services in Africa’s humanitarian settings
- Democratic Republic of the Congo Ebola cases rise, surpass previous outbreak
- Cruise ship No Sail Order extended through September 2020
- Fast-spreading mutation helps common flu subtype escape human immune response
Clinical Research News
Tulevat kliiniset tutkimukset
-
Fred Hutchinson Cancer CenterPromiCell Therapeutics, Inc.Ei vielä rekrytointiaVaihe IVB Eturauhassyöpä AJCC v8 | Metastaattinen kastraatioresistentti eturauhasen adenokarsinoomaYhdysvallat
-
Arizona State UniversityEi vielä rekrytointiaHarjoittele | Verenpaine | RavitsemustietoYhdysvallat
-
Oregon Health and Science UniversityInSightecEi vielä rekrytointia
-
Tongji HospitalEi vielä rekrytointia
-
Sakarya UniversityEi vielä rekrytointiaÄäreisvaltimotauti | Aterektomia sairaissa alaraajojen valtimoissaTurkki (Türkiye)
-
Ziauddin UniversityEi vielä rekrytointiaSacroiliac nivelen toimintahäiriö
-
Eli Lilly and CompanyEi vielä rekrytointiaLihavuus | Diabetes mellitus, tyyppi 1 | YlipainoinenYhdysvallat
-
Cairo UniversityEi vielä rekrytointiaHampaiden karies | Kohdunkaulan karies
-
IRCCS San RaffaeleEi vielä rekrytointiaHaiman kasvaimet | Radiomiikka | Haiman tiehyen adenokarsinooma (PDAC) | Endoskooppinen ultraääni (EUS) | Tekoäly (AI)Italia
-
MediLink Therapeutics (Suzhou) Co., Ltd.Ei vielä rekrytointiaMetastaattinen haimasyöpä | Haiman tiehyen adenokarsinooma (PDAC)Kiina
-
National University of Modern LanguagesEi vielä rekrytointiaKehon dysmorfinen häiriö | Positiivinen psykologia
-
Shanghai Minwei Biotechnology Co., LtdRekrytointiTyypin 2 diabetes (T2DM) | MASH - Metaboliseen toimintahäiriöön liittyvä steatohepatiitti | Ylipaino, lihavuusKiina
